Clinical Trial Update: H-Side Branch Stent, A New Stent for the Treatment of True Bifurcation Lesions [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of the H-Side Branch Stent for true bifurcation coronary lesions sponsored by Yonsei University has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• H-Side Branch Stent

Snippet

Sponsor: Yonsei University | Conditions: Coronary Artery Disease | Phase 1 | Status: WITHDRAWN